消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

中国胃黏膜癌前状态和癌前病变的处理策略专家共识（2020年）

2020-11-30 中华医学会消化病学分会 中华消化杂志.2020.40(11):731-741. 发表于上海

癌前病变胃癌前病变胃黏膜病变

慢性萎缩性胃炎和上皮内瘤变是胃癌筛查过程中常见胃黏膜病变，正确应对和处理胃黏膜癌前状态和癌前病变，对降低我国胃癌发病率意义重大。本共识在前期关于早期胃癌筛查流程和防控建议的基础上，结合我国胃癌前状态和

中文标题：

中国胃黏膜癌前状态和癌前病变的处理策略专家共识（2020年）

发布机构：

中华医学会消化病学分会

发布日期：

2020-11-30

简要介绍：

慢性萎缩性胃炎和上皮内瘤变是胃癌筛查过程中常见胃黏膜病变，正确应对和处理胃黏膜癌前状态和癌前病变，对降低我国胃癌发病率意义重大。本共识在前期关于早期胃癌筛查流程和防控建议的基础上，结合我国胃癌前状态和癌前病变的发病现状，从胃黏膜癌前状态和癌前病变的定义、诊断和分期、治疗、监测和随访４ 个方面切入，提出针对胃黏膜癌前状态和癌前病变的诊治要点和随访策略，以期对该类疾病的防控发挥指导作用，从而实现早期阻断和干预胃癌发生

 

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1240385, encodeId=fe2a124038594, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:00 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240386, encodeId=25c21240386c2, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:13 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201740, encodeId=f8021201e40da, content=胃癌前病变, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 11 16:52:31 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082364, encodeId=06c71082364b2, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:50 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072395, encodeId=f56010e23958f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a953201025, createdName=12c1b251m65暂无昵称, createdTime=Sun Nov 21 05:55:04 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2022-08-22 ms4000001002415858

    很有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1240385, encodeId=fe2a124038594, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:00 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240386, encodeId=25c21240386c2, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:13 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201740, encodeId=f8021201e40da, content=胃癌前病变, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 11 16:52:31 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082364, encodeId=06c71082364b2, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:50 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072395, encodeId=f56010e23958f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a953201025, createdName=12c1b251m65暂无昵称, createdTime=Sun Nov 21 05:55:04 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2022-08-22 ms4000001002415858

    收益很多

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1240385, encodeId=fe2a124038594, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:00 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240386, encodeId=25c21240386c2, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:13 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201740, encodeId=f8021201e40da, content=胃癌前病变, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 11 16:52:31 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082364, encodeId=06c71082364b2, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:50 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072395, encodeId=f56010e23958f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a953201025, createdName=12c1b251m65暂无昵称, createdTime=Sun Nov 21 05:55:04 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2022-03-11 ms5000001586473032

    胃癌前病变

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1240385, encodeId=fe2a124038594, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:00 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240386, encodeId=25c21240386c2, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:13 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201740, encodeId=f8021201e40da, content=胃癌前病变, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 11 16:52:31 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082364, encodeId=06c71082364b2, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:50 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072395, encodeId=f56010e23958f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a953201025, createdName=12c1b251m65暂无昵称, createdTime=Sun Nov 21 05:55:04 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1240385, encodeId=fe2a124038594, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:00 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240386, encodeId=25c21240386c2, content=收益很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0758255298, createdName=ms4000001002415858, createdTime=Mon Aug 22 22:57:13 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201740, encodeId=f8021201e40da, content=胃癌前病变, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 11 16:52:31 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082364, encodeId=06c71082364b2, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:50 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072395, encodeId=f56010e23958f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a953201025, createdName=12c1b251m65暂无昵称, createdTime=Sun Nov 21 05:55:04 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-21 12c1b251m65暂无昵称

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2019 ASCCP共识指南：宫颈癌筛查和癌前病变管理

美国阴道镜检查和宫颈病理学会(ASCCP,American Society for Colposcopy and Cervical Pathology) · 2020-04-01

肝细胞癌癌前病变的诊断和治疗多学科专家共识（2020版）

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2020-03-15

2019 ESGE/EHMSG/ESP/SPED指南：胃上皮癌前病变的管理

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2019-03-06

2018德国HPV感染及其相关病变的诊疗指南读解

暂未更新 · 2018-10-30

中国早期食管鳞状细胞癌及癌前病变筛查与诊治共识（2015年，北京）

中华医学会消化病学分会(CSGE,Chinese Society Of Gastroenterology) · 2016-01-30

拓展阅读

2015 ASGE指南：内镜在胃癌前病变和恶性肿瘤管理中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-04-29

2025 ACG临床指南：胃癌前病变的诊断和管理

美国胃肠病学院(ACG,American College of Gastroenterology) · 2025-03-12